The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

被引：0
|
作者：
Michael A Becker
H Ralph Schumacher
Luis R Espinoza
Alvin F Wells
Patricia MacDonald
Eric Lloyd
Christopher Lademacher
机构：
[1] University of Chicago Medical Center,The University of Chicago Pritzker School of Medicine, MC0930
[2] University of Pennsylvania and VA Medical Center,undefined
[3] VA Medical Center,undefined
[4] Rheumatology,undefined
[5] Louisiana State University Health Sciences Center,undefined
[6] Rosalind Franklin University of Medicine & Science,undefined
[7] Takeda Global Research & Development Center Inc.,undefined
[8] Astellas Pharma Global Development Inc.,undefined
来源：
Arthritis Research & Therapy | / 12卷 / 2期
关键词：
Gout; Allopurinol; Hyperuricemia; Febuxostat; Moderate Renal Impairment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
    Dejaco, C.
    Duftner, C.
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2010, 17 (02): : 84 - 84
  • [2] The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
    Becker, Michael A.
    Schumacher, H. Ralph
    Espinoza, Luis R.
    Wells, Alvin F.
    MacDonald, Patricia
    Lloyd, Eric
    Lademacher, Christopher
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
  • [3] Women with gout: Efficacy and safety of urate-lowering with febuxostat and allopurinol
    Chohan, Saima
    Becker, Michael A.
    MacDonald, Patricia A.
    Chefo, Solomon
    Jackson, Robert L.
    [J]. ARTHRITIS CARE & RESEARCH, 2012, 64 (02) : 256 - 261
  • [4] COMPARISON OF URATE-LOWERING EFFICACY AND SAFETY OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS
    Singh, Gajendera
    Kumar, Hemant
    Soni, Udit
    Tyagi, Shikhar
    Aggarwal, Kritika
    Verma, Kavita
    Kumar, Sumit
    [J]. HETEROCYCLIC LETTERS, 2016, 6 (01): : 133 - 147
  • [5] Urate-Lowering Therapy for Gout: Focus on Febuxostat
    Love, Bryan L.
    Barrons, Robert
    Veverka, Angie
    Snider, K. Matthew
    [J]. PHARMACOTHERAPY, 2010, 30 (06): : 594 - 608
  • [6] Outcome Of Allopurinol Or Febuxostat Treatment In Gout Patients Naive To Urate-Lowering Therapy
    Khanna, Puja
    Hatoum, Hind
    Lin, Swu-Jane
    Shiozawa, Aki
    Akhras, Kasem
    Khanna, Dinesh
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S857 - S857
  • [7] A SYSTEMATIC REVIEW OF GENETIC VARIANTS ASSOCIATED WITH THE SAFETY AND EFFICACY OF URATE-LOWERING THERAPY FOR PATIENTS WITH GOUT AND/OR HYPERURICEMIA.
    Wen, Y.
    Sayre, F.
    Nelson, J.
    Straka, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S21 - S22
  • [8] A SYSTEMATIC REVIEW OF GENETIC VARIANTS ASSOCIATED WITH THE SAFETY AND EFFICACY OF URATE-LOWERING THERAPY FOR PATIENTS WITH GOUT AND/OR HYPERURICEMIA.
    Wen, Y.
    Sayre, F.
    Nelson, J.
    Straka, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S54 - S54
  • [9] The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
    Robert L Jackson
    Barbara Hunt
    Patricia A MacDonald
    [J]. BMC Geriatrics, 12
  • [10] The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
    Jackson, Robert L.
    Hunt, Barbara
    MacDonald, Patricia A.
    [J]. BMC GERIATRICS, 2012, 12
12345